Mexico’s 2027-2028 Tender: The Procurement Race Starts Today

Guillaume Corpart

For medical equipment and supply companies operating in Mexico, the goalposts have moved. The Mexican federal government recently unveiled the framework for a 2027–2028 consolidated health sector tender, and the message to suppliers is clear: efficiency and local investment will give you a major advantage in the tender procurement process. [1]

The shift to a biennial (two-year) tender cycle by Mexican President Claudia Sheinbaum Pardo and her administration is a calculated move to end the era of fragmented, last-minute purchasing. By awarding contracts for a 24-month period, the government aims to stabilize supply chains that have been historically volatile. For the private sector, this offers a rare window of predictability — but only for those who adapt to the new requirements. [2]

The Birmex Centralization

The most significant operational shift is the total consolidation of purchasing power under Birmex (Laboratorios de Biológicos y Reactivos de México). By 2027, Birmex will not just be a buyer but the master orchestrator of logistics for the big three players in Mexican healthcare: IMSS, ISSSTE, and IMSS-Bienestar. [2]

Suppliers must prepare for more rigorous digital oversight. The government is implementing an integrated health supply chain monitoring system, designed to track deliveries in real time. [3] To win in this environment, companies must audit their own capabilities. Companies participating in the 2027-2028 tender must be able to track weekly inventory, monthly production capacity, and other key stats to meet the needs of the country’s health system. [2]

The Local Tiebreaker

Perhaps the most notable change is the official push for more local investment and involvement by the healthcare companies participating in the Mexican market. The upcoming tender will utilize a points-based evaluation system that rewards companies with a greater physical footprint in Mexico.

Points will be awarded for:

Manufacturing infrastructure: Companies with local production facilities or R&D labs will be awarded more points under the new system.
Strategic partnerships: Companies who collaborate with Birmex or Mexican universities for technology transfer are also eligible for points.
Job creation: Potential suppliers who show a demonstrable investment in the Mexican workforce will have an advantage. [1]

While a local factory is not a strict prerequisite for participation, it may serve as a tiebreaker among companies who offer similar products at a similar price. In a market where 65% of supplies are currently imported, the administration is using its purchasing power to encourage a nearshoring of the medical industry. [4]

Timelines for Success

For companies who are interested in bidding in the upcoming Mexican tender, it’s best to start your preparations now. Here’s a closer look at the upcoming timeline:

March 2026. Birmex will complete its market investigation to identify pricing trends, supply capacity, and possible suppliers.
June 2026. The Mexican government will conclude procurement planning, including evaluation criteria for suppliers.
Mid-2026. Public calls for tenders will be published and advertised.
Late 2026. Potential suppliers can submit their bids and enter the evaluation process.
Late 2026 – early 2027. Contracts for the 2027-2028 Mexican tender will be awarded. [5]

Focus Areas for Suppliers

Suppliers who are interested in submitting bids would be wise to begin gathering market intelligence. There are a few key areas that suppliers can focus on to give themselves an advantage in the upcoming tender procurement process:

Generics. The government has identified almost 400 products with expiring patents in 2026. This will open the door for new generic or bio-comparable entrants to enter the market. Tenders can be awarded to several suppliers, if prices are within 10% of the lowest bid. [6]
Local production and investment. With the increased emphasis on local infrastructure, companies who already have this presence will have an advantage in the tender process. Companies interested in procuring tenders in Mexico may want to consider increasing their presence in the market. [1]
Shoring up internal process and documentation. In several categories, including oncology, diagnostic reagents and medical consumables, potential suppliers must be able to provide weekly inventory updates, monthly production capacity, as well as details on packaging, handling and cold chain management in some cases. This is a great time for suppliers to shore up their processes to ensure they are following new Mexican standards. [2]
Pricing. Though Mexico is placing an increased emphasis on local involvement for their suppliers, the reality is that lower price is still critical for securing bids. Companies who focus on competitive pricing will hold a key advantage in the upcoming procurement process. [1]

Key Takeaways for Health Care Companies

For companies interested in continuing their involvement or gaining greater access to the Mexican healthcare marketplace, the 2027-2028 tender provides a unique opportunity. The good news for medical suppliers is that it provides more organized and cohesive requirements, with longer timelines, compared to prior tenders. This means that interested companies can transition their approach to winning tenders from crisis management to strategic forecasting. In addition, the winners in the tender process will secure coveted two-year contracts, a rare reward in the often-volatile healthcare marketplace. [2]

However, the Mexican tender will also pose new challenges for interested companies. Interested suppliers must be aware that it’s not just a sales opportunity; it’s an industrial policy. Suppliers who treat this as a traditional bid based solely on price will likely find themselves at a disadvantage. The winners will be those who align their corporate strategy with Mexico’s vision of self-sufficiency, leveraging local partnerships and robust digital logistics to secure their place in the next two-year cycle. [1]

Of course, suppliers who have participated in Mexico’s tender procurement model in the past know that challenges can exist with the system. This new model will be a test of Mexico’s health system. While the new system appears to offer many improvements over previous models, time will tell if it becomes a successful, enduring system for Mexico. Companies will need to remain agile and adaptable as they begin their strategic planning to secure bids. [2]

Next Steps

Contact GHI to learn more about the upcoming 2027-2028 Mexican tender, and how you can optimize your company’s strategy for success. Our team of researchers can provide the analysis you need to gain valuable insights to support strategic decision-making in your industry.

************

Sources:

The Birmex Centralization

The Local Tiebreaker

Timelines for Success

Focus Areas for Suppliers

Key Takeaways for Health Care Companies

Next Steps

Guillaume Corpart

Compliance Hurdles for American Medical Device Manufacturers (2026)

Related Posts

Compliance Hurdles for American Medical Device Manufacturers (2026)

Venezuela’s Healthcare Market in 2026: A High-Risk, High-Reward Pivot for Medical Device Executives

Vital Signs and Geopolitical Shifts: How US Power Plays in Latin America Will Reshape the Medical Equipment Market